BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grevet JD, Lan X, Hamagami N, Edwards CR, Sankaranarayanan L, Ji X, Bhardwaj SK, Face CJ, Posocco DF, Abdulmalik O, Keller CA, Giardine B, Sidoli S, Garcia BA, Chou ST, Liebhaber SA, Hardison RC, Shi J, Blobel GA. Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells. Science 2018;361:285-90. [PMID: 30026227 DOI: 10.1126/science.aao0932] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou P, Chan BKC, Wan YK, Yuen CTL, Choi GCG, Li X, Tong CSW, Zhong SSW, Sun J, Bao Y, Mak SYL, Chow MZY, Khaw JV, Leung SY, Zheng Z, Cheung LWT, Tan K, Wong KH, Chan HYE, Wong ASL. A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets. Cell Rep 2020;32:108020. [PMID: 32783942 DOI: 10.1016/j.celrep.2020.108020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
2 Liao R, Zheng Y, Liu X, Zhang Y, Seim G, Tanimura N, Wilson GM, Hematti P, Coon JJ, Fan J, Xu J, Keles S, Bresnick EH. Discovering How Heme Controls Genome Function Through Heme-omics. Cell Rep 2020;31:107832. [PMID: 32610133 DOI: 10.1016/j.celrep.2020.107832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Chen Z, Arai E, Khan O, Zhang Z, Ngiow SF, He Y, Huang H, Manne S, Cao Z, Baxter AE, Cai Z, Freilich E, Ali MA, Giles JR, Wu JE, Greenplate AR, Hakeem MA, Chen Q, Kurachi M, Nzingha K, Ekshyyan V, Mathew D, Wen Z, Speck NA, Battle A, Berger SL, Wherry EJ, Shi J. In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer. Cell 2021;184:1262-1280.e22. [PMID: 33636129 DOI: 10.1016/j.cell.2021.02.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Wessels MW, Cnossen MH, van Dijk TB, Gillemans N, Schmidt KLJ, van Lom K, Vinjamur DS, Coyne S, Kurita R, Nakamura Y, de Man SA, Pfundt R, Azmani Z, Brouwer RWW, Bauer DE, van den Hout MCGN, van IJcken WFJ, Philipsen S. Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency. Blood Adv 2021;5:2339-49. [PMID: 33938942 DOI: 10.1182/bloodadvances.2020003753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lan X, Ren R, Feng R, Ly LC, Lan Y, Zhang Z, Aboreden N, Qin K, Horton JR, Grevet JD, Mayuranathan T, Abdulmalik O, Keller CA, Giardine B, Hardison RC, Crossley M, Weiss MJ, Cheng X, Shi J, Blobel GA. ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression. Mol Cell 2021;81:239-254.e8. [PMID: 33301730 DOI: 10.1016/j.molcel.2020.11.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
6 Peslak SA, Khandros E, Huang P, Lan X, Geronimo CL, Grevet JD, Abdulmalik O, Zhang Z, Giardine BM, Keller CA, Shi J, Hardison RC, Blobel GA. HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation. Blood Adv 2020;4:4560-72. [PMID: 32956454 DOI: 10.1182/bloodadvances.2020002475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Andrieu-Soler C, Soler E. When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies. Curr Opin Hematol 2020;27:141-8. [PMID: 32167946 DOI: 10.1097/MOH.0000000000000577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Amjad F, Fatima T, Fayyaz T, Khan MA, Qadeer MI. Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review). Biomed Rep 2020;13:48. [PMID: 32953110 DOI: 10.3892/br.2020.1355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li J, Zhou Z, Sun HX, Ouyang W, Dong G, Liu T, Ge L, Zhang X, Liu C, Gu Y. Transcriptome Analyses of β-Thalassemia -28(A>G) Mutation Using Isogenic Cell Models Generated by CRISPR/Cas9 and Asymmetric Single-Stranded Oligodeoxynucleotides (assODNs). Front Genet 2020;11:577053. [PMID: 33193694 DOI: 10.3389/fgene.2020.577053] [Reference Citation Analysis]
10 Frati G, Miccio A. Genome Editing for β-Hemoglobinopathies: Advances and Challenges. J Clin Med 2021;10:482. [PMID: 33525591 DOI: 10.3390/jcm10030482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chen JJ. HRI stress signaling and HbF production. Blood 2020;135:2113-4. [PMID: 32526022 DOI: 10.1182/blood.2020006300] [Reference Citation Analysis]
12 Bhattacharjee G, Gohil N, Khambhati K, Mani I, Maurya R, Karapurkar JK, Gohil J, Chu DT, Vu-Thi H, Alzahrani KJ, Show PL, Rawal RM, Ramakrishna S, Singh V. Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications. J Control Release 2022:S0168-3659(22)00080-3. [PMID: 35149141 DOI: 10.1016/j.jconrel.2022.02.005] [Reference Citation Analysis]
13 Lin Z, King R, Tang V, Myers G, Balbin-Cuesta G, Friedman A, McGee B, Desch K, Ozel AB, Siemieniak D, Reddy P, Emmer B, Khoriaty R. The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion. Mol Cell Biol 2020;40:e00180-20. [PMID: 32989016 DOI: 10.1128/MCB.00180-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Doudna JA. The promise and challenge of therapeutic genome editing. Nature 2020;578:229-36. [DOI: 10.1038/s41586-020-1978-5] [Cited by in Crossref: 165] [Cited by in F6Publishing: 129] [Article Influence: 82.5] [Reference Citation Analysis]
15 Lin J, Ye Y, Shang X, Zhang Y, Wei X, Xu X. TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the γ-globin gene promoters. Br J Haematol 2021. [PMID: 34569056 DOI: 10.1111/bjh.17786] [Reference Citation Analysis]
16 Katsantoni E. Omics Studies in Hemoglobinopathies. Mol Diagn Ther 2019;23:223-34. [PMID: 30712217 DOI: 10.1007/s40291-019-00386-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
17 Ma S, Lv J, Feng Z, Rong Z, Lin Y. Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs. J Gene Med 2021;:e3377. [PMID: 34270141 DOI: 10.1002/jgm.3377] [Reference Citation Analysis]
18 Wang E, Zhou H, Nadorp B, Cayanan G, Chen X, Yeaton AH, Nomikou S, Witkowski MT, Narang S, Kloetgen A, Thandapani P, Ravn-Boess N, Tsirigos A, Aifantis I. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation. Cell Stem Cell 2021;28:718-731.e6. [PMID: 33450187 DOI: 10.1016/j.stem.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wienert B, Martyn GE, Funnell APW, Quinlan KGR, Crossley M. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies. Trends Genet 2018;34:927-40. [PMID: 30287096 DOI: 10.1016/j.tig.2018.09.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
20 Hariharan P, Nadkarni A. Insight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets. Blood Rev 2021;49:100823. [PMID: 33726930 DOI: 10.1016/j.blre.2021.100823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Koreman GT, Xu Y, Hu Q, Zhang Z, Allen SE, Wolfner MF, Wang B, Han C. Upgraded CRISPR/Cas9 tools for tissue-specific mutagenesis in Drosophila. Proc Natl Acad Sci U S A 2021;118:e2014255118. [PMID: 33782117 DOI: 10.1073/pnas.2014255118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Cosenza LC, Gasparello J, Romanini N, Zurlo M, Zuccato C, Gambari R, Finotti A. Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients. Mol Ther Methods Clin Dev 2021;21:507-23. [PMID: 33997100 DOI: 10.1016/j.omtm.2021.03.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Steinberg MH. Fetal hemoglobin in sickle cell anemia. Blood 2020;136:2392-400. [PMID: 32808012 DOI: 10.1182/blood.2020007645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
24 Eckl EM, Ziegemann O, Krumwiede L, Fessler E, Jae LT. Sensing, signaling and surviving mitochondrial stress. Cell Mol Life Sci 2021;78:5925-51. [PMID: 34228161 DOI: 10.1007/s00018-021-03887-7] [Reference Citation Analysis]
25 Chen Z, Devi G, Arif A, Zamore PD, Sontheimer EJ, Watts JK. Tetrazine-Ligated CRISPR sgRNAs for Efficient Genome Editing. ACS Chem Biol 2022. [PMID: 35446558 DOI: 10.1021/acschembio.2c00116] [Reference Citation Analysis]
26 Brown A, Baird MR, Yip MC, Murray J, Shao S. Structures of translationally inactive mammalian ribosomes. Elife 2018;7:e40486. [PMID: 30355441 DOI: 10.7554/eLife.40486] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
27 Yin J, Spillman E, Cheng ES, Short J, Chen Y, Lei J, Gibbs M, Rosenthal JS, Sheng C, Chen YX, Veerasammy K, Choetso T, Abzalimov R, Wang B, Han C, He Y, Yuan Q. Brain-specific lipoprotein receptors interact with astrocyte derived apolipoprotein and mediate neuron-glia lipid shuttling. Nat Commun 2021;12:2408. [PMID: 33893307 DOI: 10.1038/s41467-021-22751-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Cao Z, Budinich KA, Huang H, Ren D, Lu B, Zhang Z, Chen Q, Zhou Y, Huang YH, Alikarami F, Kingsley MC, Lenard AK, Wakabayashi A, Khandros E, Bailis W, Qi J, Carroll MP, Blobel GA, Faryabi RB, Bernt KM, Berger SL, Shi J. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Mol Cell 2021:S1097-2765(21)00587-6. [PMID: 34358447 DOI: 10.1016/j.molcel.2021.07.018] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Himadewi P, Wang XQD, Feng F, Gore H, Liu Y, Yu L, Kurita R, Nakamura Y, Pfeifer GP, Liu J, Zhang X. 3'HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression. Elife 2021;10:e70557. [PMID: 34585664 DOI: 10.7554/eLife.70557] [Reference Citation Analysis]
30 Demirci S, Leonard A, Tisdale JF. Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies. Hum Mol Genet 2020;29:R100-6. [PMID: 32406490 DOI: 10.1093/hmg/ddaa088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
31 Steinberg MH. Targeting fetal hemoglobin expression to treat β hemoglobinopathies. Expert Opin Ther Targets 2022. [PMID: 35418266 DOI: 10.1080/14728222.2022.2066519] [Reference Citation Analysis]
32 Yin J, Xie X, Ye Y, Wang L, Che F. BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases. Biosci Rep 2019;39:BSR20190604. [PMID: 31654056 DOI: 10.1042/BSR20190604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
33 Zhang Y, Hyle J, Wright S, Shao Y, Zhao X, Zhang H, Li C. A cis-element within the ARF locus mediates repression of p16 INK4A expression via long-range chromatin interactions. Proc Natl Acad Sci U S A 2019:201909720. [PMID: 31818950 DOI: 10.1073/pnas.1909720116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
34 Jost M, Santos DA, Saunders RA, Horlbeck MA, Hawkins JS, Scaria SM, Norman TM, Hussmann JA, Liem CR, Gross CA, Weissman JS. Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs. Nat Biotechnol 2020;38:355-64. [PMID: 31932729 DOI: 10.1038/s41587-019-0387-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 20.5] [Reference Citation Analysis]
35 Liu Y, Zhang C, Wang X, Li X, You C. CRISPR/Cas9 Technology and Its Application in Horticultural Crops. Horticultural Plant Journal 2022. [DOI: 10.1016/j.hpj.2022.04.007] [Reference Citation Analysis]
36 Bao X, Zhang X, Wang L, Wang Z, Huang J, Zhang Q, Ye Y, Liu Y, Chen D, Zuo Y, Liu Q, Xu P, Huang B, Fang J, Lao J, Feng X, Li Y, Kurita R, Nakamura Y, Yu W, Ju C, Huang C, Mohandas N, Li D, Zhao C, Xu X. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia. Am J Hum Genet 2021;108:709-21. [PMID: 33735615 DOI: 10.1016/j.ajhg.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Veeneman B, Gao Y, Grant J, Fruhling D, Ahn J, Bosbach B, Bienkowska J, Follettie M, Arndt K, Myers J, Zhong W. PINCER: improved CRISPR/Cas9 screening by efficient cleavage at conserved residues. Nucleic Acids Res 2020;48:9462-77. [PMID: 32821942 DOI: 10.1093/nar/gkaa645] [Reference Citation Analysis]
38 Khandros E, Huang P, Peslak SA, Sharma M, Abdulmalik O, Giardine BM, Zhang Z, Keller CA, Hardison RC, Blobel GA. Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts. Blood 2020;135:1957-68. [PMID: 32268371 DOI: 10.1182/blood.2020005058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
39 Demirci S, Leonard A, Haro-Mora JJ, Uchida N, Tisdale JF. CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges. Adv Exp Med Biol 2019;1144:37-52. [PMID: 30715679 DOI: 10.1007/5584_2018_331] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
40 Guo X, Plank-Bazinet J, Krivega I, Dale RK, Dean A. Embryonic erythropoiesis and hemoglobin switching require transcriptional repressor ETO2 to modulate chromatin organization. Nucleic Acids Res 2020;48:10226-40. [PMID: 32960220 DOI: 10.1093/nar/gkaa736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Demirci S, Leonard A, Essawi K, Tisdale JF. CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease. Mol Ther Methods Clin Dev 2021;23:276-85. [PMID: 34729375 DOI: 10.1016/j.omtm.2021.09.010] [Reference Citation Analysis]
42 Zhang Q, Fu Y, Thakur C, Bi Z, Wadgaonkar P, Qiu Y, Xu L, Rice M, Zhang W, Almutairy B, Chen F. CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA. Biochem Biophys Res Commun 2020;528:54-61. [PMID: 32460957 DOI: 10.1016/j.bbrc.2020.04.145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Venkatesan V, Srinivasan S, Babu P, Thangavel S. Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies. Mol Cell Biol 2020;41:e00253-20. [PMID: 33077498 DOI: 10.1128/MCB.00253-20] [Reference Citation Analysis]
44 Lan X, Khandros E, Huang P, Peslak SA, Bhardwaj SK, Grevet JD, Abdulmalik O, Wang H, Keller CA, Giardine B, Baeza J, Duffner ER, El Demerdash O, Wu XS, Vakoc CR, Garcia BA, Hardison RC, Shi J, Blobel GA. The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells. Blood Adv 2019;3:1586-97. [PMID: 31126914 DOI: 10.1182/bloodadvances.2019032318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
45 Davis R, Gurumurthy A, Hossain MA, Gunn EM, Bungert J. Engineering Globin Gene Expression. Mol Ther Methods Clin Dev 2019;12:102-10. [PMID: 30603654 DOI: 10.1016/j.omtm.2018.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
46 Liu H, Wang L, Luo Y. Blossom of CRISPR technologies and applications in disease treatment. Synth Syst Biotechnol 2018;3:217-28. [PMID: 30370342 DOI: 10.1016/j.synbio.2018.10.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
47 Gurumurthy A, Wu Q, Nar R, Paulsen K, Trumbull A, Fishman RC, Brand M, Strouboulis J, Qian Z, Bungert J. TFII-I/Gtf2i and Erythro-Megakaryopoiesis. Front Physiol 2020;11:590180. [PMID: 33101065 DOI: 10.3389/fphys.2020.590180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Karayel Ö, Xu P, Bludau I, Velan Bhoopalan S, Yao Y, Ana Rita FC, Santos A, Schulman BA, Alpi AF, Weiss MJ, Mann M. Integrative proteomics reveals principles of dynamic phosphosignaling networks in human erythropoiesis. Mol Syst Biol 2020;16:e9813. [PMID: 33259127 DOI: 10.15252/msb.20209813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
49 Sjögren SE, Chen J, Mattebo A, Alattar AG, Karlsson H, Siva K, Soneji S, Tedgård U, Chen JJ, Gram M, Flygare J. Targeting elevated heme levels to treat a mouse model for Diamond-Blackfan Anemia. Exp Hematol 2021:S0301-472X(21)00369-6. [PMID: 34757171 DOI: 10.1016/j.exphem.2021.10.005] [Reference Citation Analysis]
50 Papayannopoulou T. Control of fetal globin expression in man: new opportunities to challenge past discoveries. Exp Hematol 2020;92:43-50. [PMID: 32976950 DOI: 10.1016/j.exphem.2020.09.195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Park SH, Bao G. CRISPR/Cas9 gene editing for curing sickle cell disease. Transfus Apher Sci 2021;60:103060. [PMID: 33455878 DOI: 10.1016/j.transci.2021.103060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Oseghale AR, Zhu X, Li B, Peterson KR, Nudelman A, Rephaeli A, Xu H, Pace BS. Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice. Blood Cells Mol Dis 2019;79:102345. [PMID: 31351219 DOI: 10.1016/j.bcmd.2019.102345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
53 Bagchi A, Nath A, Thamodaran V, Ijee S, Palani D, Rajendiran V, Venkatesan V, Datari P, Pai AA, Janet NB, Balasubramanian P, Nakamura Y, Srivastava A, Mohankumar KM, Thangavel S, Velayudhan SR. Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells. Cells 2021;10:523. [PMID: 33804564 DOI: 10.3390/cells10030523] [Reference Citation Analysis]
54 Boontanrart MY, Schröder MS, Stehli GM, Banović M, Wyman SK, Lew RJ, Bordi M, Gowen BG, DeWitt MA, Corn JE. ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin. Cell Rep 2020;32:107993. [PMID: 32755585 DOI: 10.1016/j.celrep.2020.107993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Xie S, Ji Z, Suo T, Li B, Zhang X. Advancing sensing technology with CRISPR: From the detection of nucleic acids to a broad range of analytes - A review. Anal Chim Acta 2021;1185:338848. [PMID: 34711331 DOI: 10.1016/j.aca.2021.338848] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Chen JJ, Zhang S. Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies. Blood 2019;134:1697-707. [PMID: 31554636 DOI: 10.1182/blood.2019001915] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
57 Vatikioti A, Karkoulia E, Ioannou M, Strouboulis J. Translational regulation and deregulation in erythropoiesis. Exp Hematol 2019;75:11-20. [PMID: 31154069 DOI: 10.1016/j.exphem.2019.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Liu L, Zhu X, Yu A, Ward CM, Pace BS. δ-Aminolevulinate induces fetal hemoglobin expression by enhancing cellular heme biosynthesis. Exp Biol Med (Maywood) 2019;244:1220-32. [PMID: 31475864 DOI: 10.1177/1535370219872995] [Reference Citation Analysis]
59 Huang P, Peslak SA, Lan X, Khandros E, Yano JA, Sharma M, Keller CA, Giardine B, Qin K, Abdulmalik O, Hardison RC, Shi J, Blobel GA. The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression. Blood 2020;135:2121-32. [PMID: 32299090 DOI: 10.1182/blood.2020005301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
60 Zhou Y, Petrovic J, Zhao J, Zhang W, Bigdeli A, Zhang Z, Berger SL, Pear WS, Faryabi RB. EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells. Mol Cell 2022:S1097-2765(22)00058-2. [PMID: 35182476 DOI: 10.1016/j.molcel.2022.01.015] [Reference Citation Analysis]
61 Zhang X, Lv S, Luo Z, Hu Y, Peng X, Lv J, Zhao S, Feng J, Huang G, Wan QL, Liu J, Huang H, Luan B, Wang D, Zhao X, Lin Y, Zhou Q, Zhang ZN, Rong Z. MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo. Nucleic Acids Res 2021;49:4171-85. [PMID: 33751124 DOI: 10.1093/nar/gkab174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Cucolo L, Chen Q, Qiu J, Yu Y, Klapholz M, Budinich KA, Zhang Z, Shao Y, Brodsky IE, Jordan MS, Gilliland DG, Zhang NR, Shi J, Minn AJ. The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade. Immunity 2022;55:671-685.e10. [PMID: 35417675 DOI: 10.1016/j.immuni.2022.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Khandros E, Blobel GA. Heterogeneity of fetal hemoglobin production in adult red blood cells. Curr Opin Hematol 2021;28:164-70. [PMID: 33631783 DOI: 10.1097/MOH.0000000000000640] [Reference Citation Analysis]
64 Bao X, Zuo Y, Chen D, Zhao C. DNA methylation patterns of β-globin cluster in β-thalassemia patients. Clin Epigenetics 2020;12:187. [PMID: 33272312 DOI: 10.1186/s13148-020-00987-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Cheng L, Li Y, Qi Q, Xu P, Feng R, Palmer L, Chen J, Wu R, Yee T, Zhang J, Yao Y, Sharma A, Hardison RC, Weiss MJ, Cheng Y. Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression. Nat Genet 2021;53:869-80. [PMID: 33958780 DOI: 10.1038/s41588-021-00861-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]